302 related articles for article (PubMed ID: 11574213)
1. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters.
Salakou S; Tsamandas AC; Bonikos DS; Papapetropoulos T; Dougenis D
Eur J Cardiothorac Surg; 2001 Oct; 20(4):712-21. PubMed ID: 11574213
[TBL] [Abstract][Full Text] [Related]
2. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
[TBL] [Abstract][Full Text] [Related]
3. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
Shen G; Chai Y; Yue L; Wei HQ; Lin M
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039
[TBL] [Abstract][Full Text] [Related]
4. Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.
Gilhus NE; Jones M; Turley H; Gatter KC; Nagvekar N; Newsom-Davis J; Willcox N
J Clin Pathol; 1995 May; 48(5):447-55. PubMed ID: 7629292
[TBL] [Abstract][Full Text] [Related]
5. Maximal thymectomy for myasthenia gravis.
Ashour MH; Jain SK; Kattan KM; al-Daeef AQ; Abdal Jabbar MS; al-Tahan AR; al-Moallami M
Eur J Cardiothorac Surg; 1995; 9(8):461-4. PubMed ID: 7495591
[TBL] [Abstract][Full Text] [Related]
6. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma.
Zhang M; Zhou Y; Guo J; Li H; Tian F; Gong L; Wang X; Lan M; Li Z; Zhang W
Exp Neurol; 2014 Apr; 254():200-5. PubMed ID: 24518487
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
8. [Surgical therapy of myasthenia gravis and thymoma].
Bertram P; Treutner KH; Winkeltau G; Schumpelick V
Chirurg; 1993 Oct; 64(10):796-801. PubMed ID: 8269744
[TBL] [Abstract][Full Text] [Related]
9. Microscopic-sized "microthymoma" in patients with myasthenia gravis.
Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Yoshioka M; Iyama KI
Chest; 2007 Mar; 131(3):847-849. PubMed ID: 17356102
[TBL] [Abstract][Full Text] [Related]
10. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
[TBL] [Abstract][Full Text] [Related]
11. A nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).
Cornea R; Lazăr E; Dema A; Herman D
Rom J Morphol Embryol; 2009; 50(4):729-31. PubMed ID: 19942974
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Bcl-2 protein in the myasthenic thymus.
Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
Zhang Y; Yu L; Jing Y; Ke J
Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
[TBL] [Abstract][Full Text] [Related]
14. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of thymectomy in myasthenia gravis.
Hayat G; Mohyuddin YA; Naunheim K
Mo Med; 1995 May; 92(5):252-7. PubMed ID: 7791734
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and therapy of thymus tumors].
Wolff H; Naundorf M
Zentralbl Chir; 1991; 116(1):3-13. PubMed ID: 2038898
[TBL] [Abstract][Full Text] [Related]
17. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy.
Nicolaou S; Müller NL; Li DK; Oger JJ
Radiology; 1996 Nov; 201(2):471-4. PubMed ID: 8888243
[TBL] [Abstract][Full Text] [Related]
18. Modified maximal thymectomy for thymic epithelial tumors: predictors of survival and neurological outcome in patients with thymomatous myasthenia gravis.
Prokakis C; Koletsis E; Apostolakis E; Zolota V; Chroni E; Baltayiannis N; Chatzimichalis A; Dougenis D
World J Surg; 2009 Aug; 33(8):1650-8. PubMed ID: 19506940
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.
Bouchikh M; Zouaidia F; Benhaddou EHA; Mahassini N; Achir A; El Malki HO
Rev Neurol (Paris); 2017 Jun; 173(6):388-395. PubMed ID: 28461027
[TBL] [Abstract][Full Text] [Related]
20. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.
Nakahara K; Nakane S; Nakajima M; Yamashita S; Mori T; Ando Y
J Neuroimmunol; 2017 Apr; 305():182-185. PubMed ID: 28100409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
